VT News
Michael Mørkøv

Michael Mørkøv

Ask VT AI
View News Summary
  • USMNT schedules key September friendlies against South Korea and Japan as part of 2026 World Cup preparations
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Democratic backlash erupts over Rep. Thanedar's unilateral impeachment push against Trump, seen as self-serving and disruptive by party leaders.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • USMNT schedules key September friendlies against South Korea and Japan as part of 2026 World Cup preparations
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • Democratic backlash erupts over Rep. Thanedar's unilateral impeachment push against Trump, seen as self-serving and disruptive by party leaders.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Michael Mørkøv

Top Topics

Trending in U.S.

World

Sport